GB965174A - Thiodisalicylates of substituted quinolines - Google Patents

Thiodisalicylates of substituted quinolines

Info

Publication number
GB965174A
GB965174A GB1659062A GB1659062A GB965174A GB 965174 A GB965174 A GB 965174A GB 1659062 A GB1659062 A GB 1659062A GB 1659062 A GB1659062 A GB 1659062A GB 965174 A GB965174 A GB 965174A
Authority
GB
United Kingdom
Prior art keywords
thiodisalicylates
substituted quinolines
salts
formulae
parenteral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1659062A
Inventor
Charles Henry Grogan
Charles Freeman Geschickter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GESCHICKTER FUND MED RES
Original Assignee
GESCHICKTER FUND MED RES
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GESCHICKTER FUND MED RES filed Critical GESCHICKTER FUND MED RES
Priority to GB1659062A priority Critical patent/GB965174A/en
Publication of GB965174A publication Critical patent/GB965174A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/40—Nitrogen atoms attached in position 8
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention comprises the salts of formulae: <FORM:0965174/C1/1> and <FORM:0965174/C1/2> They are made by reaction of thiodisalicylic acid and the appropriate quinoline in organic solvents. Pharmaceutical compositions containing these salts together with a carrier are mentioned for oral (tablets, capsules) and parenteral (solutions) administration against arthritis.
GB1659062A 1962-05-01 1962-05-01 Thiodisalicylates of substituted quinolines Expired GB965174A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB1659062A GB965174A (en) 1962-05-01 1962-05-01 Thiodisalicylates of substituted quinolines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1659062A GB965174A (en) 1962-05-01 1962-05-01 Thiodisalicylates of substituted quinolines

Publications (1)

Publication Number Publication Date
GB965174A true GB965174A (en) 1964-07-29

Family

ID=10080075

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1659062A Expired GB965174A (en) 1962-05-01 1962-05-01 Thiodisalicylates of substituted quinolines

Country Status (1)

Country Link
GB (1) GB965174A (en)

Similar Documents

Publication Publication Date Title
IL38364A (en) 8-azapurin-6-one derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL38342A (en) Bis(3,5-dixopiperazin-1-yl)alkane compounds and pharmaceutical compositions containing them
IL36211A0 (en) N(6)-aralkyl-adenosine derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
GB1004310A (en) 1,6-dimethyl-ergoline i derivatives
IL39851A0 (en) Phenanthridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL40931A0 (en) Tetrahydrocarbazole derivatives,their manufacture and pharmaceutical compositions containing them
GB965174A (en) Thiodisalicylates of substituted quinolines
GB1013910A (en) New derivative of gitoxin, the use and preparation thereof
ES362231A1 (en) Dimethylbiguanide Derivative
IL36286A0 (en) Erythromycylamine compounds,process for the preparation thereof and pharmaceutical compositions containing the same
IL37586A0 (en) Indolylacetic acid derivatives and salts thereof,processes for their preparation and pharmaceutical compositions containing the same
IL36285A0 (en) Erythromycylamine compounds,processes for preparation thereof and pharmaceutical compositions containing them
GB1000781A (en) ª†-morpholinobutyrophenone and its salts
GB914512A (en) Novel therapeutic compositions
AU441022B2 (en) An improved capsule for containing an article (divisional of 408,028)
GB1028201A (en) A new salt of n-methylglucamine and a process for its preparation
IL37702A (en) Boric acid complexes of optionally n-substituted dopamine compounds,the corresponding n-substituted dopamine compounds and pharmaceutical compositions containing the latter
GB1047911A (en) Glutamine salts
GB1028815A (en) Amine salts
SE388124B (en) PROCEDURE FOR PREPARING A PHARMACEUTICAL COMPOSITION CONTAINING ACCTYLSALICYLIC ACID AND D-PROPOXYPHEN HYDROCHLORIDE (D-4-DIMETY AMINO-3-METHYL-1,2-DIPHENYL-BUTANOL)
IL30856A0 (en) New phenanthridine derivatives,processes for their preparation and pharmaceutical compositions containing them
GB1025799A (en) 2-phenylcyclopropylguanidine
GB829616A (en) Choline gentisate
GB991153A (en) Colchiceine derivative
GB1046167A (en) Novel amine salts